Hepatocyte Growth Factor and Cardiovascular Autonomic Function

This study has been completed.

First Received: May 23, 2007 No Changes Posted

Sponsored by:	Oita Red Cross Hospital
Information provided by:	Oita Red Cross Hospital
ClinicalTrials.gov Identifier:	NCT00478127

Purpose

In this study, we tested the hypothesis that elevated HGF is associated with insulin resistance and cardiovascular autonomic dysfunction in type 2 diabetic patients not receiving insulin treatment.

Condition
Type-2 Diabetes

MedlinePlus related topics: Diabetes

U.S. FDA Resources

Study Type:	Observational
Study Design:	Cross-Sectional, Random Sample, Retrospective Study

Eligibility

Genders Eligible for Study:

Both

Criteria

Inclusion Criteria: - Type-2 diabetes Exclusion Criteria: - Type-1 diabetes

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00478127

Sponsors and Collaborators

Oita Red Cross Hospital

Investigators

Principal Investigator:

Futoshi Anan

Oita Red Cross Hospital

More Information

No publications provided

Study ID Numbers:	AO-272
Study First Received:	May 23, 2007
Last Updated:	May 23, 2007
ClinicalTrials.gov Identifier:	NCT00478127 History of Changes
Health Authority:	Japan: Institutional Review Board

Study placed in the following topic categories:

Metabolic Diseases
Diabetes Mellitus, Type 2
Diabetes Mellitus
Mitogens

Endocrine System Diseases
Endocrinopathy
Glucose Metabolism Disorders
Metabolic Disorder

Additional relevant MeSH terms:

Metabolic Diseases
Diabetes Mellitus, Type 2
Diabetes Mellitus
Endocrine System Diseases
Glucose Metabolism Disorders

ClinicalTrials.gov processed this record on May 07, 2009